Clinical trial
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous…
NCT00336531 · Samsung Medical Center, Other · Completed
Key facts
| NCT number | NCT00336531 |
|---|---|
| Title | Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation |
| Official title | Clinical Study to Evaluate the Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors |
| Lead sponsor | Samsung Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neuroblastoma, Brain Tumor, Retinoblastoma, Wilms Tumor, Mycoses |
| Intervention type | Drug |
| Interventions | itraconazole |
| Enrollment | 100 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jun 13, 2006 |
| Last update posted | Nov 19, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: